135 related articles for article (PubMed ID: 10862618)
1. Geldanamycin induces ErbB-2 degradation by proteolytic fragmentation.
Tikhomirov O; Carpenter G
J Biol Chem; 2000 Aug; 275(34):26625-31. PubMed ID: 10862618
[TBL] [Abstract][Full Text] [Related]
2. Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation.
Tikhomirov O; Carpenter G
Cancer Res; 2003 Jan; 63(1):39-43. PubMed ID: 12517775
[TBL] [Abstract][Full Text] [Related]
3. Caspase-dependent cleavage of ErbB-2 by geldanamycin and staurosporin.
Tikhomirov O; Carpenter G
J Biol Chem; 2001 Sep; 276(36):33675-80. PubMed ID: 11402024
[TBL] [Abstract][Full Text] [Related]
4. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin.
Mimnaugh EG; Chavany C; Neckers L
J Biol Chem; 1996 Sep; 271(37):22796-801. PubMed ID: 8798456
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy.
Citri A; Alroy I; Lavi S; Rubin C; Xu W; Grammatikakis N; Patterson C; Neckers L; Fry DW; Yarden Y
EMBO J; 2002 May; 21(10):2407-17. PubMed ID: 12006493
[TBL] [Abstract][Full Text] [Related]
6. Effects of the tyrosine-kinase inhibitor geldanamycin on ligand-induced Her-2/neu activation, receptor expression and proliferation of Her-2-positive malignant cell lines.
Hartmann F; Horak EM; Cho C; Lupu R; Bolen JB; Stetler-Stevenson MA; Pfreundschuh M; Waldmann TA; Horak ID
Int J Cancer; 1997 Jan; 70(2):221-9. PubMed ID: 9009164
[TBL] [Abstract][Full Text] [Related]
7. The function of steroid hormone receptors is inhibited by the hsp90-specific compound geldanamycin.
Segnitz B; Gehring U
J Biol Chem; 1997 Jul; 272(30):18694-701. PubMed ID: 9228040
[TBL] [Abstract][Full Text] [Related]
8. Geldanamycin-associated inhibition of intracellular trafficking is attributed to a co-purified activity.
Barzilay E; Ben-Califa N; Supino-Rosin L; Kashman Y; Hirschberg K; Elazar Z; Neumann D
J Biol Chem; 2004 Feb; 279(8):6847-52. PubMed ID: 14660597
[TBL] [Abstract][Full Text] [Related]
9. Degradation signals in ErbB-2 dictate proteasomal processing and immunogenicity and resist protection by cis glycine-alanine repeat.
Piechocki MP; Pilon SA; Kelly C; Wei WZ
Cell Immunol; 2001 Sep; 212(2):138-49. PubMed ID: 11748930
[TBL] [Abstract][Full Text] [Related]
10. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90.
Xu W; Mimnaugh E; Rosser MF; Nicchitta C; Marcu M; Yarden Y; Neckers L
J Biol Chem; 2001 Feb; 276(5):3702-8. PubMed ID: 11071886
[TBL] [Abstract][Full Text] [Related]
12. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation.
Vecchi M; Baulida J; Carpenter G
J Biol Chem; 1996 Aug; 271(31):18989-95. PubMed ID: 8702564
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mineralocorticoid and glucocorticoid receptor function by the heat shock protein 90-binding agent geldanamycin.
Bamberger CM; Wald M; Bamberger AM; Schulte HM
Mol Cell Endocrinol; 1997 Aug; 131(2):233-40. PubMed ID: 9296382
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
15. Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.
Murakami Y; Fukazawa H; Mizuno S; Uehara Y
Biol Pharm Bull; 1998 Oct; 21(10):1030-5. PubMed ID: 9821805
[TBL] [Abstract][Full Text] [Related]
16. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin.
Schulte TW; Neckers LM
Cancer Chemother Pharmacol; 1998; 42(4):273-9. PubMed ID: 9744771
[TBL] [Abstract][Full Text] [Related]
17. Intracellular retention and degradation of the epidermal growth factor receptor, two distinct processes mediated by benzoquinone ansamycins.
Supino-Rosin L; Yoshimura A; Yarden Y; Elazar Z; Neumann D
J Biol Chem; 2000 Jul; 275(29):21850-5. PubMed ID: 10806200
[TBL] [Abstract][Full Text] [Related]
18. p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2.
Chavany C; Mimnaugh E; Miller P; Bitton R; Nguyen P; Trepel J; Whitesell L; Schnur R; Moyer J; Neckers L
J Biol Chem; 1996 Mar; 271(9):4974-7. PubMed ID: 8617772
[TBL] [Abstract][Full Text] [Related]
19. Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases.
Yorgin PD; Hartson SD; Fellah AM; Scroggins BT; Huang W; Katsanis E; Couchman JM; Matts RL; Whitesell L
J Immunol; 2000 Mar; 164(6):2915-23. PubMed ID: 10706677
[TBL] [Abstract][Full Text] [Related]
20. The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells.
Xu W; Yuan X; Jung YJ; Yang Y; Basso A; Rosen N; Chung EJ; Trepel J; Neckers L
Cancer Res; 2003 Nov; 63(22):7777-84. PubMed ID: 14633703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
